Hers vs Zealthy
Hers has an open FDA warning letter dated September 9, 2025. Zealthy has an open FDA warning letter dated September 9, 2025. No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
Hers / Zealthy
Hers
6.8/10
Zealthy
5.6/10
- Apostrophe Pharmacy LLCtype not stated
- XeCare LLCtype not stated
- MedisourceRx503B
Neither Hers nor Zealthy pays us. Links to them earn nothing. Scores: Hers 6.8, Zealthy 5.6. How we are paid
What the record shows
- 01
Hers has an open FDA warning letter dated September 9, 2025. Zealthy has an open FDA warning letter dated September 9, 2025.
- 02
Hers names three pharmacies. Zealthy names no compounding pharmacy in our record.
- 03
No price lines up like for like. They share compounded semaglutide injection, but Zealthy's $286 covers the medication only, with a separate membership on top.
- 04
Only Hers lists a price for brand-name tirzepatide pen. Only Zealthy lists a price for compounded tirzepatide injection.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
Hers
Zealthy
$199/mo
$2,388 a year
$286/mo
medication only, membership extra; not compared
$351/mo
medication only, membership extra; not compared
$299/mo
medication only, membership extra; not compared
Read off each seller’s own pages. Hers: September 28, 2026. Zealthy: October 17, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for Hers
6.8/10- Sells brand-name tirzepatide pen, which Zealthy does not price
- Names its compounding pharmacy
- Open FDA warning letter, September 9, 2025
- Price leaves out clinician visits and coaching
The case for Zealthy
5.6/10- Sells compounded tirzepatide injection, which Hers does not price
- Price includes clinician visits and coaching
- Open FDA warning letter, September 9, 2025
- Names no compounding pharmacy
- Lowest price covers the medication only, with a separate membership on top
Scores
Hers 6.8 · Zealthy 5.6 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
Hers vs Zealthy: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- bmiMD8.2
From $129/mo prepaid
Visit site - Collective9.1
From $59/mo
Visit site - Embody9.3
From $79/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks